$AMD
ADVANCED MICRO DEVICES INC Stock $amd

$amd Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000162828021001185 Filed on January 29, 2021

Income Statement

Concept	2020 Q4	2020 Q3	2020 Q2
Revenue	$3.244B	$2.801B	$1.932B
YoY Change	52.52%	55.52%	26.19%
Cost Of Revenue	$1.793B	$1.571B	$1.084B
YoY Change	52.21%	53.42%	19.12%
Gross Profit	$1.451B	$1.230B	$848.0M
YoY Change	52.9%	58.3%	36.55%
Gross Profit Margin	44.73%	43.91%	43.89%
Selling, General & Admin	$308.0M	$273.0M	$215.0M
YoY Change	49.51%	47.57%	13.76%
% of Gross Profit	21.23%	22.2%	25.35%
Research & Development	$573.0M	$508.0M	$460.0M
YoY Change	45.06%	25.12%	23.32%
% of Gross Profit	39.49%	41.3%	54.25%
Depreciation & Amortization	$90.00M	$82.00M	$72.00M
YoY Change	40.63%	36.67%	38.46%
% of Gross Profit	6.2%	6.67%	8.49%
Operating Expenses	$881.0M	$781.0M	$675.0M
YoY Change	46.59%	32.15%	20.11%
Operating Profit	$570.0M	$449.0M	$173.0M
YoY Change	63.79%	141.4%	193.22%
Interest Expense	$9.000M	$11.00M	$14.00M
YoY Change	-50.0%	-54.17%	-44.0%
% of Operating Profit	1.58%	2.45%	8.09%
Other Income/Expense, Net	-$15.00M	-$37.00M	$1.000M
YoY Change	-88.0%	2.78%	-66.67%
Pretax Income	$546.0M	$401.0M	$160.0M
YoY Change	166.34%	218.25%	332.43%
Income Tax	-$1.232B	$12.00M	$4.000M
% Of Pretax Income	-225.64%	2.99%	2.5%
Net Earnings	$1.781B	$390.0M	$157.0M
YoY Change	947.65%	225.0%	348.57%
Net Earnings / Revenue	54.9%	13.92%	8.13%
Basic Earnings Per Share	$1.48	$0.33	$0.13
Diluted Earnings Per Share	$1.45	$0.32	$0.13
COMMON SHARES
Basic Shares Outstanding	1.205B shares	1.184B shares	1.174B shares
Diluted Shares Outstanding	1.226B shares	1.215B shares	1.227B shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.290B	$1.771B	$1.775B
YoY Change	52.36%	46.48%	57.36%
Cash & Equivalents	$1.595B	$1.296B	$1.775B
Short-Term Investments	$695.0M	$475.0M	$0.00
Other Short-Term Assets	$388.0M	$303.0M	$221.0M
YoY Change	53.36%	12.22%	-20.5%
Inventory	$1.399B	$1.292B	$1.324B
Prepaid Expenses
Receivables	$2.066B	$2.134B	$1.789B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.143B	$5.500B	$5.109B
YoY Change	33.63%	40.59%	36.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$641.0M	$595.0M	$585.0M
YoY Change	28.2%	31.35%	27.73%
Goodwill	$289.0M	$289.0M	$289.0M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$63.00M	$60.00M	$59.00M
YoY Change	8.62%	1.69%	1.72%
Other Assets	$373.0M	$364.0M	$326.0M
YoY Change	4.48%	8.66%	-1.51%
Total Long-Term Assets	$2.819B	$1.523B	$1.474B
YoY Change	97.0%	13.57%	9.35%
TOTAL ASSETS
Total Short-Term Assets	$6.143B	$5.500B	$5.109B
Total Long-Term Assets	$2.819B	$1.523B	$1.474B
Total Assets	$8.962B	$7.023B	$6.583B
YoY Change	48.67%	33.7%	29.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$468.0M	$752.0M	$802.0M
YoY Change	-52.63%	-1.44%	-3.14%
Accrued Expenses	$1.796B	$1.478B	$1.172B
YoY Change	65.68%	76.58%	61.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$200.0M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.417B	$2.417B	$2.434B
YoY Change	2.46%	29.67%	34.92%
LONG-TERM LIABILITIES
Long-Term Debt	$330.0M	$373.0M	$490.0M
YoY Change	-32.1%	-57.22%	-52.47%
Other Long-Term Liabilities	$177.0M	$161.0M	$150.0M
YoY Change	12.74%	15.0%	-3.23%
Total Long-Term Liabilities	$507.0M	$534.0M	$640.0M
YoY Change	-21.15%	-47.23%	-46.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.417B	$2.417B	$2.434B
Total Long-Term Liabilities	$507.0M	$534.0M	$640.0M
Total Liabilities	$2.924B	$2.951B	$3.074B
YoY Change	-2.6%	2.61%	2.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.605B	-$6.386B	-$6.776B
YoY Change	-35.1%	-12.1%	-8.25%
Common Stock	$10.56B	$10.37B	$10.14B
YoY Change	5.82%	9.19%	8.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$131.0M	$126.0M	$54.00M
YoY Change	147.17%	137.74%	8.0%
Treasury Stock Shares	6.000M shares	6.000M shares	5.000M shares
Shareholders Equity	$5.837B	$3.867B	$3.305B
YoY Change
Total Liabilities & Shareholders Equity	$8.962B	$7.023B	$6.583B
YoY Change	48.67%	33.7%	29.03%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	$1.781B	$390.0M	$157.0M
YoY Change	947.65%	225.0%	348.57%
Depreciation, Depletion And Amortization	$90.00M	$82.00M	$72.00M
YoY Change	40.63%	36.67%	38.46%
Cash From Operating Activities	$554.0M	$339.0M	$243.0M
YoY Change	25.34%	44.87%	710.0%
INVESTING ACTIVITIES
Capital Expenditures	-$74.00M	-$74.00M	-$91.00M
YoY Change	76.19%	34.55%	56.9%
Acquisitions
YoY Change
Other Investing Activities	-$220.0M	-$475.0M	$55.00M
YoY Change	-1475.0%	-524.11%	7.84%
Cash From Investing Activities	-$294.0M	-$549.0M	-$36.00M
YoY Change	1030.77%	-1063.16%	414.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	35.00M	-269.0M	238.0M
YoY Change	-132.71%	174.49%	-726.32%
NET CHANGE
Cash From Operating Activities	554.0M	339.0M	243.0M
Cash From Investing Activities	-294.0M	-549.0M	-36.00M
Cash From Financing Activities	35.00M	-269.0M	238.0M
Net Change In Cash	295.0M	-479.0M	445.0M
YoY Change	-4.53%	-348.19%	-3066.67%
FREE CASH FLOW
Cash From Operating Activities	$554.0M	$339.0M	$243.0M
Capital Expenditures	-$74.00M	-$74.00M	-$91.00M
Free Cash Flow	$628.0M	$413.0M	$334.0M
YoY Change	29.75%	42.91%	279.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	us-gaap	Gross Profit GrossProfit	2447000000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1983000000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1547000000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1434000000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	995000000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	750000000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	562000000	USD
CY2020	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2019	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	60000000	USD
CY2019	us-gaap	Depreciation Depreciation	142000000	USD
CY2018	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0000002488
CY2018	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201601Member
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:LiabilitiesCurrent
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-26
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-26
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-07882
CY2020	dei	Entity Registrant Name EntityRegistrantName	ADVANCED MICRO DEVICES, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-1692300
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	2485 Augustine Drive
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Clara
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95054
CY2020	dei	City Area Code CityAreaCode	408
CY2020	dei	Local Phone Number LocalPhoneNumber	749-4000
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2020	dei	Trading Symbol TradingSymbol	AMD
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	58500000000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1211280009	shares
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	338000000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	338000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9763000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6731000000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6475000000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5416000000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3863000000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4028000000	USD
CY2020	us-gaap	Gross Profit GrossProfit	4347000000	USD
CY2019	us-gaap	Gross Profit GrossProfit	2868000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	1369000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	631000000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	451000000	USD
CY2020	us-gaap	Interest Expense InterestExpense	47000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	94000000	USD
CY2018	us-gaap	Interest Expense InterestExpense	121000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-165000000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1275000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	372000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	330000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1210000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9000000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5000000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2490000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	341000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	337000000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.10
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1184000000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1091000000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	982000000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1207000000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1120000000	shares
CY2018	us-gaap	Depreciation Depreciation	94000000	USD
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1064000000	shares
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2490000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	341000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	337000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	17000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	8000000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-14000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2507000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	349000000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	325000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1595000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1466000000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	695000000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	37000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2066000000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1859000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1399000000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	982000000	USD
CY2020Q4	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	10000000	USD
CY2019Q4	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	20000000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	378000000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	233000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	6143000000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	4597000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	641000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	500000000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	208000000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	205000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	289000000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	289000000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	63000000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	58000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1245000000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	22000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	373000000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	357000000	USD
CY2020Q4	us-gaap	Assets Assets	8962000000	USD
CY2019Q4	us-gaap	Assets Assets	6028000000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	468000000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	988000000	USD
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	78000000	USD
CY2019Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	213000000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1796000000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1084000000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	75000000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	74000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2417000000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2359000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	330000000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	486000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	201000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	201000000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	199000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	177000000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	157000000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2250000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1217000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1175000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1211000000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1170000000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	12000000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	12000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	10544000000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9963000000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6000000	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5000000	shares
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	131000000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	53000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4605000000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7095000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17000000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5837000000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2827000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8962000000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6028000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5837000000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2827000000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1266000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2490000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	341000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	337000000	USD
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	312000000	USD
CY2019	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	222000000	USD
CY2018	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	170000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	274000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	197000000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	137000000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	14000000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	30000000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	38000000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	42000000	USD
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	36000000	USD
CY2018	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-176000000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12000000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-33000000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-42000000	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-27000000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	45000000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1223000000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-7000000	USD
CY2018	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-4000000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6000000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2000000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	219000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	623000000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	806000000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	417000000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	137000000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	151000000	USD
CY2020	amd	Increase Decreasein Prepayments Related Parties IncreaseDecreaseinPrepaymentsRelatedParties	-10000000	USD
CY2019	amd	Increase Decreasein Prepayments Related Parties IncreaseDecreaseinPrepaymentsRelatedParties	-14000000	USD
CY2018	amd	Increase Decreasein Prepayments Related Parties IncreaseDecreaseinPrepaymentsRelatedParties	28000000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	231000000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	176000000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	70000000	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-135000000	USD
CY2019	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	7000000	USD
CY2018	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	35000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-513000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	153000000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	212000000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	574000000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	220000000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	81000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1071000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	493000000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	294000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	217000000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	163000000	USD
CY2020	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	850000000	USD
CY2019	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	284000000	USD
CY2018	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	123000000	USD
CY2020	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	192000000	USD
CY2019	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	325000000	USD
CY2018	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	45000000	USD
CY2020	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	0	USD
CY2019	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	25000000	USD
CY2018	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	71000000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-2000000	USD
CY2018	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-952000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-149000000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-170000000	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	200000000	USD
CY2019	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2018	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	200000000	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	473000000	USD
CY2018	us-gaap	Repayments Of Debt RepaymentsOfDebt	41000000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	449000000	USD
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	85000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	74000000	USD
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	70000000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	78000000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6000000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6000000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	USD
CY2018	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	5000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43000000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	125000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	387000000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-108000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1470000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1083000000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1191000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1595000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1470000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1083000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	31000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	67000000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	79000000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8000000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-4000000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-8000000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	31000000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	65000000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	49000000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	217000000	USD
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	377000000	USD
CY2018	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	111000000	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	115000000	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	28000000	USD
CY2020	amd	Issuance Of Treasury Stock To Partially Settle Debt IssuanceOfTreasuryStockToPartiallySettleDebt	0	USD
CY2019	amd	Issuance Of Treasury Stock To Partially Settle Debt IssuanceOfTreasuryStockToPartiallySettleDebt	7000000	USD
CY2018	amd	Issuance Of Treasury Stock To Partially Settle Debt IssuanceOfTreasuryStockToPartiallySettleDebt	141000000	USD
CY2020	amd	Deferred Proceeds On Sale Of Receivable DeferredProceedsOnSaleOfReceivable	0	USD
CY2019	amd	Deferred Proceeds On Sale Of Receivable DeferredProceedsOnSaleOfReceivable	0	USD
CY2018	amd	Deferred Proceeds On Sale Of Receivable DeferredProceedsOnSaleOfReceivable	25000000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	45000000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22000000	USD
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1595000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1466000000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1078000000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	4000000	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1595000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1470000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1083000000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	691000000	USD
CY2020	us-gaap	Fiscal Period FiscalPeriod	<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company uses a 52- or 53-week fiscal year ending on the last Saturday in December. Fiscal 2020, 2019 and 2018 ended December 26, 2020, December 28, 2019 and December 29, 2018, respectively. Fiscal 2020, 2019 and 2018 each consisted of 52 weeks.</span>
CY2020	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassification. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform to current period presentation.</span>
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results are likely to differ from those estimates, and such differences may be material to the financial statements. Areas where management uses subjective judgment include, but are not limited to, revenue allowances, inventory valuation, valuation and assessing potential impairment, if any, of goodwill and deferred income taxes.</span>
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	167000000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	197000000	USD
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	314000000	USD
CY2019	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	217000000	USD
CY2018	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	176000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1399000000	USD
CY2020Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	123000000	USD
CY2019Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	197000000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	93000000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	94000000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1139000000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	982000000	USD
CY2020Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	208000000	USD
CY2019Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	203000000	USD
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1209000000	USD
CY2019Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	951000000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	136000000	USD
CY2019Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	114000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1553000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1268000000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	912000000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	768000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	641000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	500000000	USD
CY2020	us-gaap	Depreciation Depreciation	217000000	USD
CY2020Q4	amd	Software Technology And Licenses Net Noncurrent SoftwareTechnologyAndLicensesNetNoncurrent	229000000	USD
CY2019Q4	amd	Software Technology And Licenses Net Noncurrent SoftwareTechnologyAndLicensesNetNoncurrent	210000000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	144000000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	147000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	373000000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	357000000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	513000000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	285000000	USD
CY2020Q4	amd	Accrued Marketing And Advertising Current AccruedMarketingAndAdvertisingCurrent	839000000	USD
CY2019Q4	amd	Accrued Marketing And Advertising Current AccruedMarketingAndAdvertisingCurrent	454000000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	444000000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	345000000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1796000000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1084000000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2000000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11000000	USD
CY2020	amd	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	22000000	USD
CY2019	amd	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	43000000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-9000000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-52000000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15000000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2000000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	337000000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	174000000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	338000000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	563000000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	330000000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	486000000	USD
CY2016Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	8.00
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54000000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	312000000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	26000000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	338000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	2490000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	341000000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	337000000	USD
CY2020	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	1000000	USD
CY2019	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2018	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2020	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	2491000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	341000000	USD
CY2018	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	337000000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1184000000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1091000000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	982000000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	20000000	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	29000000	shares
CY2018	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	82000000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3000000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1207000000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1120000000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1064000000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.10
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	274000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	197000000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	137000000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-42000000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	232000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	197000000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	137000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	38000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	214000000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.75
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	29000000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	25000000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	21000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1213000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	334000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	114000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	67000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1280000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	372000000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	328000000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-13000000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	12000000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5000000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	8000000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	50000000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-17000000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13000000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	38000000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5000000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1193000000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-28000000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2000000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7000000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-4000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1223000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7000000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1210000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9000000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	269000000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	78000000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	69000000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-6000000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1000000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1000000	USD
CY2020	amd	Foreign Withholding Tax Expense Income ForeignWithholdingTaxExpenseIncome	10000000	USD
CY2019	amd	Foreign Withholding Tax Expense Income ForeignWithholdingTaxExpenseIncome	22000000	USD
CY2018	amd	Foreign Withholding Tax Expense Income ForeignWithholdingTaxExpenseIncome	-29000000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3000000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	2000000	USD
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	2000000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1301000000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-59000000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-64000000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	57000000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	0	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1000000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-116000000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	0	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	0	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	-13000000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	13000000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-6000000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1210000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9000000	USD
CY2020	amd	Foreign Withholding Tax Expense Income ForeignWithholdingTaxExpenseIncome	10000000	USD
CY2020	amd	Withholdingtaxesoncrossbordertransactions Withholdingtaxesoncrossbordertransactions	13000000	USD
CY2019	amd	Income Tax Refundsfromforeign Jurisdictionrelatedtolegalsettlement IncomeTaxRefundsfromforeignJurisdictionrelatedtolegalsettlement	22000000	USD
CY2019	amd	Foreign Withholding Tax Expense Income ForeignWithholdingTaxExpenseIncome	22000000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	-13000000	USD
CY2018	amd	Income Tax Refundsfromforeign Jurisdictionrelatedtolegalsettlement IncomeTaxRefundsfromforeignJurisdictionrelatedtolegalsettlement	36000000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	13000000	USD
CY2018	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	7000000	USD
CY2018	amd	Withholdingtaxesoncrossbordertransactions Withholdingtaxesoncrossbordertransactions	7000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1029000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1357000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	514000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	257000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	59000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	50000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	569000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	584000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	489000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	429000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	174000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	232000000	USD
CY2020Q4	amd	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	72000000	USD
CY2019Q4	amd	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	57000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	149000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	105000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2996000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3071000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1576000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2867000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1420000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	204000000	USD
CY2020Q4	amd	Deferred Tax Liability Right Of Use Asset DeferredTaxLiabilityRightOfUseAsset	62000000	USD
CY2019Q4	amd	Deferred Tax Liability Right Of Use Asset DeferredTaxLiabilityRightOfUseAsset	49000000	USD
CY2020Q4	amd	Deferred Tax Liabilities Discount On Notes Payable DeferredTaxLiabilitiesDiscountOnNotesPayable	2000000	USD
CY2019Q4	amd	Deferred Tax Liabilities Discount On Notes Payable DeferredTaxLiabilitiesDiscountOnNotesPayable	16000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	114000000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	111000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	8000000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	17000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	186000000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	193000000	USD
CY2020Q4	amd	Deferred Tax Assets Liabilities Noncurrent Net DeferredTaxAssetsLiabilitiesNoncurrentNet	1234000000	USD
CY2019Q4	amd	Deferred Tax Assets Liabilities Noncurrent Net DeferredTaxAssetsLiabilitiesNoncurrentNet	11000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2867000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2443000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2621000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1576000000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2867000000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2443000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1245000000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	22000000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11000000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11000000	USD
CY2020Q4	amd	Deferred Tax Assets Liabilities Noncurrent Net DeferredTaxAssetsLiabilitiesNoncurrentNet	1234000000	USD
CY2019Q4	amd	Deferred Tax Assets Liabilities Noncurrent Net DeferredTaxAssetsLiabilitiesNoncurrentNet	11000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1600000000	USD
CY2020Q4	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability	304000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	65000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	49000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	49000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	41000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	5000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	15000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	30000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	15000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	3000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	2000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	119000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	65000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	49000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	77000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	17000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	9000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9763000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6731000000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6475000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	1369000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	631000000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	451000000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	56000000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9763000000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6731000000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6475000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	641000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	500000000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8000000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15000000	USD
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-176000000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12000000	USD
CY2020	amd	Other Miscellaneous Expense Income Net OtherMiscellaneousExpenseIncomeNet	1000000	USD
CY2019	amd	Other Miscellaneous Expense Income Net OtherMiscellaneousExpenseIncomeNet	4000000	USD
CY2018	amd	Other Miscellaneous Expense Income Net OtherMiscellaneousExpenseIncomeNet	6000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-165000000	USD
CY2018	us-gaap	Operating Lease Expense OperatingLeaseExpense	53000000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	27000000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	25000000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	55000000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	47000000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M21D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0529
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	52000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	55000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	48000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	41000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	34000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	54000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	284000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	42000000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	242000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	201000000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	201000000	USD
CY2020Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	3026000000	USD
CY2020Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	71000000	USD
CY2020Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	34000000	USD
CY2020Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	25000000	USD
CY2020Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	23000000	USD
CY2020Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	12000000	USD
CY2020Q4	us-gaap	Purchase Obligation PurchaseObligation	3191000000	USD
CY2020	amd	Product Warranty Period ProductWarrantyPeriod	P1Y
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	15000000	USD
CY2018Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	13000000	USD
CY2020	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	82000000	USD
CY2019	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	31000000	USD
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	60000000	USD
CY2019	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	29000000	USD
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37000000	USD
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	15000000	USD
CY2020	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	Contingencies<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Derivative Lawsuits (Wessels, Hamilton and Ha)</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2014, a purported shareholder derivative lawsuit captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wessels v. Read, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1:14 cv-262486 (Wessels) was filed against the Company (as a nominal defendant only) and certain of its directors and officers in the Santa Clara County Superior Court of the State of California. The complaint purports to assert claims against the Company and certain individual directors and officers for breach of fiduciary duty, waste of corporate assets and unjust enrichment. The complaint seeks damages allegedly caused by alleged materially misleading statements and/or material omissions by the Company and the individual directors and officers regarding its 32nm technology and “Llano” product, which statements and omissions, the plaintiffs claim, allegedly operated to artificially inflate the price paid for the Company’s common stock during the period. On April 27, 2015, a similar purported shareholder derivative lawsuit captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Christopher Hamilton and David Hamilton v. Barnes, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 5:15-cv-01890 (Hamilton) was filed against the Company (as a nominal defendant only) and certain of its directors and officers in the United States District Court for the Northern District of California.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 29, 2015, a similar purported shareholder derivative lawsuit captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jake Ha v Caldwell, et al., </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Case No. 3:15-cv-04485 (Ha) was filed against the Company (as a nominal defendant only) and certain of its directors and officers in the United States District Court for the Northern District of California. The lawsuit also seeks a court order voiding the stockholder vote on the Company’s 2015 proxy. The case was transferred to the judge handling the Hamilton Lawsuit and is now Case No. 4:15-cv-04485. The Wessels, Hamilton and Ha shareholder derivative lawsuits were stayed pending resolution of a class action lawsuit captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hatamian v. AMD, et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, C.A. No. 3:14-cv-00226 filed against the Company in the United States District Court for the Northern District of California (the Hatamian Lawsuit). The Hatamian Lawsuit asserted claims against the Company and certain of its officers for alleged violations of Section 10(b) of the Exchange Act of 1934, as amended (the Exchange Act), and SEC Rule 10b-5 concerning certain statements regarding its 32nm technology and “Llano” products. On October 9, 2017, the parties signed a definitive settlement agreement resolving the Hatamian Lawsuit and submitted it to the Court for approval. Under the terms of this agreement, the settlement was funded entirely by certain of the </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company’s insurance carriers and the defendants continued to deny any liability or wrongdoing. On March 2, 2018, the court approved the settlement and entered a final judgment in the Hatamian Lawsuit.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 30, 2018, the Wessels and Hamilton plaintiffs amended their complaints. On February 2, 2018, the Ha plaintiff also filed an amended complaint. On February 22, 2018, the Company filed motions to dismiss the Hamilton and Ha plaintiffs’ amended complaints. On April 2, 2018, the Company filed a demurrer seeking to dismiss the Wessels amended complaint. On July 23, 2018, the Santa Clara Superior Court sustained the Company’s demurrer in the Wessels case, dismissing all claims in that matter with prejudice. The Wessels plaintiff filed a Notice of Appeal on September 27, 2018. On October 4, 2018, the Federal Court issued an order dismissing the Hamilton and Ha amended complaints. The Hamilton plaintiffs filed a Notice of Appeal on October 8, 2018, and the Ha plaintiffs filed a Notice of Appeal on October 15, 2018. On November 19, 2018, the Hamilton and Ha plaintiffs filed a motion seeking summary reversal of the order dismissing their claims. The Company opposed this motion on December 13, 2018, and the Court denied it on February 25, 2019. On March 16, 2020, the Ninth Circuit affirmed the district court’s dismissal of the Ha complaint and the time to seek further appeals has since expired. On the same day, the Ninth Circuit also reversed and remanded the district court’s dismissal of the Hamilton complaint for further consideration of defendants’ motion to dismiss. Following supplemental briefing, that motion to dismiss remains pending. On August 27, 2020, the California Court of Appeal affirmed the district court’s dismissal of the Wessels complaint and the time to seek further appeals has since expired.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hauck et al. Litigation</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 19, 2018, three putative class action complaints have been filed against the Company in the United States District Court for the Northern District of California: (1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diana Hauck et al. v. AMD, Inc.,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Case No. 5:18-cv-0047, filed on January 19, 2018; (2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brian Speck et al. v. AMD, Inc.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 5:18-cv-0744, filed on February 4, 2018; and (3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nathan Barnes and Jonathan Caskey-Medina, et al. v. AMD, Inc.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 5:18-cv-00883, filed on February 9, 2018. On April 9, 2018, the court consolidated these cases and ordered that </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diana Hauck et al. v. AMD, Inc.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> serve as the lead case. On June 13, 2018, six plaintiffs (from California, Louisiana, Florida, and Massachusetts) filed a consolidated amended complaint alleging that the Company failed to disclose its processors’ alleged vulnerability to Spectre. Plaintiffs further allege that the Company’s processors cannot perform at their advertised processing speeds without exposing consumers to Spectre, and that any “patches” to remedy this security vulnerability will result in degradation of processor performance. The plaintiffs seek damages under several causes of action on behalf of a nationwide class and four state subclasses (California, Florida, Massachusetts, Louisiana) of consumers who purchased the Company’s processors and/or devices containing AMD processors. The plaintiffs also seek attorneys’ fees, equitable relief, and restitution. Pursuant to the court’s order directing the parties to litigate only eight of the causes of action in the consolidated amended complaint initially, the Company filed a motion to dismiss on July 13, 2018. On October 29, 2018, after the plaintiffs voluntarily dismissed one of their claims, the court granted the Company’s motion and dismissed six causes of action with leave to amend. The plaintiffs filed their amended consolidated complaint on December 6, 2018. On January 3, 2019, the Company again moved to dismiss the subset of claims currently at issue. On April 4, 2019, the court granted the Company’s motion and dismissed all claims currently at issue with prejudice. </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2019, the court granted the parties’ stipulation and request under Fed. R. Civ. P. 54(b) to enter a partial final judgment and certify for appeal the court’s April 4, 2019 dismissal order, and on that same date, the plaintiffs voluntarily dismissed without prejudice their remaining claims pursuant to an agreement whereby, subject to certain terms and conditions, the Company agreed to toll the statute of limitations and/or statute of repose. On May 30, 2019, the plaintiffs filed a Notice of Appeal with the U.S. Court of Appeals for the Ninth Circuit. Briefing has completed for the appeal. On May 15, 2020, the Ninth Circuit affirmed the district court’s ruling dismissing the subset of claims currently at issue against the Company. On August 14, 2020, the district court dismissed the remaining claims with prejudice.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quarterhill Inc. Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2018, three entities named Aquila Innovations, Inc. (Aquila), Collabo Innovations, Inc. (Collabo), and Polaris Innovations, Ltd. (Polaris), filed separate patent infringement complaints against the Company in the United States District Court for the Western District of Texas. Aquila alleges that the Company infringes two patents (6,239,614 and 6,895,519) relating to power management; Collabo alleges that the Company infringes one patent (7,930,575) related to power management; and Polaris alleges that the Company infringes two patents (6,728,144 </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 8,117,526) relating to control or use of dynamic random-access memory, or DRAM. Each of the three complaints seeks unspecified monetary damages, interest, fees, expenses, and costs against the Company; Aquila and Collabo also seek enhanced damages. Aquila, Collabo, and Polaris each appear to be related to a patent assertion entity named Quarterhill Inc. (formerly WiLAN Inc.). On November 16, 2018, AMD filed answers in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collabo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aquila</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases and filed a motion to dismiss in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polaris</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. On January 25, 2019, the Company filed amended answers and counterclaims in the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collabo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aquila</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases. </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 22, 2019, the Company’s motion to dismiss in the Polaris case was denied. On August 23, 2019, the Court held a claim construction hearing in each case. On May 14, 2020, at the request of Polaris, the Court dismissed all claims related to one of the two patents in suite in the </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polaris</span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. On June 10, 2020, the Court granted AMD’s motions to stay the </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Polaris</span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aquila</span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases pending the completion of </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter</span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">partes</span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of each of the patents-in-suit in those cases by the Patent Trial and Appeals Board.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Monterey Research Litigation</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2019, Monterey Research, LLC filed a patent infringement complaint against the Company in the United States District Court for the District of Delaware. Monterey Research alleges that the Company infringes six U.S. patents: 6,534,805 (related to SRAM cell design); 6,629,226 (related to read interface protocols); 6,651,134 (related to memory devices); 6,765,407 (related to programmable digital circuits); 6,961,807 (related to integrated circuits and associated memory systems); and 8,373,455 (related to output buffer circuits). Monterey Research seeks unspecified monetary damages, enhanced damages, interest, fees, expenses, costs, and injunctive relief against the Company. On January 22, 2020, the Company filed a motion to dismiss part of Monterey Research’s complaint. On February 5, 2020, Monterey Research filed an amended complaint. On February 19, 2020, the Company filed a renewed motion to dismiss part of Monterey Research’s complaint. On October 13, 2020, the Court granted-in-part and denied-in-part the Company’s renewed motion to dismiss. On October 27, 2020, the Company filed its answer to Monterey’s complaint and also filed counterclaims based on Monterey’s breach of the parties’ pre-suit non-disclosure agreement. On December 1, 2020, Monterey filed a motion to dismiss the Company’s counterclaims. On January 5, 2021, the Court granted the Company’s motion to stay the litigation pending </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the patents-in-suit by the Patent Trial and Appeals Board. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">City of Pontiac Police and Fire Retirement System Litigation</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 29, 2020, the City of Pontiac Police and Fire Retirement System, an AMD shareholder, filed a shareholder derivative complaint (the “Complaint”) against AMD and the members of its Board of Directors (collectively, “Defendants”) in the United States District Court for the Northern District of California. See City of Pontiac Police and Fire Retirement System v. Caldwell, et al., No. 5:20-cv-6794 (N.D. Cal.). The Complaint alleges that Defendants breached their fiduciary duties, violated Section 14(a) of the Exchange Act of 1934, and were unjustly enriched by misrepresenting the Company’s commitment to diversity, particularly with respect to the composition of the membership of AMD’s Board of Directors and senior leadership team. On December 18, 2020, Defendants filed a motion to dismiss the Complaint.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Xilinx Acquisition Litigation</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 26, 2020, the Company, its wholly owned subsidiary, Thrones Merger Sub, Inc., and Xilinx, Inc. (“Xilinx”) entered a definitive agreement (the “Merger Agreement”) in which the Company will acquire Xilinx by merging Thrones Merger Sub, Inc. with and into Xilinx, with Xilinx continuing as the surviving corporation and becoming a wholly owned subsidiary of the Company (the “Proposed Transaction”). See Note 18 of Notes to Consolidated Financial Statements for additional information. On December 3, 2020, the Company and Xilinx filed a Registration Statement on Form S-4 (together with the joint proxy statement and prospectus contained therein, the “Registration Statement”) describing the Proposed Transaction and other related matters. On December 11, 2020, a Xilinx shareholder filed a putative class action in the New York State Supreme Court, New York County, regarding the Proposed Transaction. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nunez v. Xilinx</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 656971/2020 (N.Y. Sup. Ct.). The lawsuit alleges that the Board of Directors of Xilinx breached their fiduciary duties to Xilinx shareholders in connection with the Proposed Transaction </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by allegedly failing to obtain fair, adequate and maximum consideration for Xilinx shareholders in connection with the Proposed Transaction and by not disclosing certain material information about the Proposed Transaction in the Registration Statement. The lawsuit asserts a single claim against the Company, alleging that it aided and abetted the Xilinx directors’ breach of their fiduciary duties. The lawsuit seeks to enjoin or rescind any transaction with Xilinx as well as certain other equitable relief, unspecified damages and attorneys’ fees and costs.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 15, 2020, a Xilinx shareholder filed a lawsuit in the United States District Court for the Southern District of New York, regarding the Proposed Transaction. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shumacher v. Xilinx</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1:20-cv-10595 (S.D.N.Y.). The lawsuit alleges that Xilinx and its Board of Directors disseminated a false and misleading Registration Statement that omitted material information regarding the Proposed Transaction, thereby violating Section 14(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The lawsuit also asserts a single claim against the Company, alleging that it acted as a controlling person of Xilinx within the meaning of Section 20(a) of the Exchange Act by virtue of its supervisory control over the composition of the Registration Statement. The lawsuit seeks to enjoin or rescind any transaction with Xilinx as well as certain other equitable relief, unspecified damages and attorneys’ fees and costs.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2020, a shareholder of the Company filed a lawsuit in the United States District Court of the Southern District of New York regarding the Proposed Transaction. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vazirani v. Advanced Micro Devices</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1:20-cv-10894 (S.D.N.Y). The lawsuit alleges that the Company and its Board of Directors disseminated a false and misleading Registration Statement that omitted material information regarding the Proposed Transaction, thereby violating Sections 14(a) and 20(a) of the Exchange Act. The lawsuit seeks to enjoin or rescind any transaction with Xilinx as well as certain other equitable relief, unspecified damages and attorneys’ fees and costs.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Link Systems Litigation</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, Future Link Systems, LLC filed a patent infringement complaint against the Company in the United States District Court for the Western District of Texas. Future Link Systems alleges that the Company infringes three U.S. patents: 7,983,888 (related to simulated PCI express circuitry); 6,363,466 (related to out of order data transactions); and 6,622,108 (related to interconnect testing). Future Link Systems seeks unspecified monetary damages, enhanced damages, interest, fees, expenses, costs, and injunctive relief against the Company. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Matters</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a responsible party on Superfund clean-up orders for three sites in Sunnyvale, California that are on the National Priorities List. Since 1981, the Company has discovered hazardous material releases to the groundwater from former underground tanks and proceeded to investigate and conduct remediation at these three sites. The chemicals released into the groundwater were commonly used in the semiconductor industry in the United States in the wafer fabrication process prior to 1979.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1991, the Company received Final Site Clean-up Requirements Orders from the California Regional Water Quality Control Board relating to the three sites. The Company has entered into settlement agreements with other responsible parties on two of the orders. During the term of such agreements, other parties have agreed to assume most of the foreseeable costs as well as the primary role in conducting remediation activities under the orders. The Company remains responsible for additional costs beyond the scope of the agreements as well as all remaining costs in the event that the other parties do not fulfill their obligations under the settlement agreements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address anticipated future remediation costs under the orders, the Company has computed and recorded an estimated environmental liability of approximately $4 million and has not recorded any potential insurance recoveries in determining the estimated costs of the cleanup. The progress of future remediation efforts cannot be predicted with certainty and these costs may change. The Company believes that any amount in addition to what has already been accrued would not be material.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Legal Matters</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant or plaintiff in various actions that arose in the normal course of business. With respect to these matters, based on the management’s current knowledge, the Company believes that the amount or range </span></div>of reasonably possible loss, if any, will not, either individually or in the aggregate, have a material adverse effect on the Company’s financial position, results of operations, or cash flows.
CY2020Q4	amd	Site Contingency Numberof Sites SiteContingencyNumberofSites	3	site
CY2020Q4	amd	Site Contingency Numberof Sites SiteContingencyNumberofSites	3	site
CY2020Q4	amd	Site Contingency Numberof Sites SiteContingencyNumberofSites	3	site
CY2020Q4	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	4000000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3244000000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2801000000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1932000000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1786000000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2127000000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1801000000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1531000000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1272000000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1793000000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1571000000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1084000000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	968000000	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1178000000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1024000000	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	910000000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	751000000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	1451000000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	1230000000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	848000000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	818000000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	949000000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	777000000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	621000000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	521000000	USD
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	573000000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	508000000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	460000000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	442000000	USD
CY2019Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	395000000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	406000000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	373000000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	373000000	USD
CY2020Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	308000000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	273000000	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	215000000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	199000000	USD
CY2019Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	206000000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	185000000	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	189000000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	170000000	USD
CY2020Q4	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2020Q3	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2020Q2	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2020Q1	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2019Q4	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2019Q3	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2019Q2	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	0	USD
CY2019Q1	amd	Gain Loss On Licensing Agreement GainLossOnLicensingAgreement	60000000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	570000000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	449000000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	173000000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	177000000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	348000000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	186000000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	59000000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	38000000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	9000000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	11000000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	14000000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	13000000	USD
CY2019Q4	us-gaap	Interest Expense InterestExpense	18000000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	24000000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	25000000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	27000000	USD
CY2020Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-37000000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000000	USD
CY2019Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-125000000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-36000000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7000000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	546000000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	401000000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	160000000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	168000000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	205000000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	126000000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	37000000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4000000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1232000000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12000000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13000000	USD
CY2020Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1000000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1000000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2019Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1000000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1000000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	1781000000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	390000000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	157000000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	162000000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	170000000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	120000000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	35000000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	16000000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.48
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.45
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1205000000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1184000000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1174000000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1170000000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1140000000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1097000000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1084000000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1044000000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1226000000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1215000000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1227000000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1224000000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1188000000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1117000000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1109000000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1094000000	shares

Files In Submission

Name	View Source	Status
0001628280-21-001185-index-headers.html	Edgar Link	completed
0001628280-21-001185-index.html	Edgar Link	completed
0001628280-21-001185.txt	Edgar Link	completed
0001628280-21-001185-xbrl.zip	Edgar Link	completed
amd-20201226.htm	Edgar Link	completed
amd-20201226.xsd	Edgar Link	completed
amd-20201226_cal.xml	Edgar Link	unprocessable
amd-20201226_def.xml	Edgar Link	unprocessable
amd-20201226_g1.jpg	Edgar Link	completed
amd-20201226_g2.jpg	Edgar Link	completed
amd-20201226_htm.xml	Edgar Link	completed
amd-20201226_lab.xml	Edgar Link	unprocessable
amd-20201226_pre.xml	Edgar Link	unprocessable
ex21-10kfy20.htm	Edgar Link	completed
ex23-10kfy20.htm	Edgar Link	completed
ex24-10kfy20.htm	Edgar Link	completed
ex311-10kfy20.htm	Edgar Link	completed
ex312-10kfy20.htm	Edgar Link	completed
ex321-10kfy20.htm	Edgar Link	completed
ex3210kfy20.htm	Edgar Link	completed
ex322-10kfy20.htm	Edgar Link	completed
exh10_58jetpolicy1x25x2021.htm	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	completed
image_01.jpg	Edgar Link	completed
image_01a.jpg	Edgar Link	completed
image_02.jpg	Edgar Link	completed
image_21.jpg	Edgar Link	completed
MetaLinks.json	Edgar Link	completed
R1.htm	Edgar Link	completed
R10.htm	Edgar Link	completed
R11.htm	Edgar Link	completed
R12.htm	Edgar Link	completed
R13.htm	Edgar Link	completed
R14.htm	Edgar Link	completed
R15.htm	Edgar Link	completed
R16.htm	Edgar Link	completed
R17.htm	Edgar Link	completed
R18.htm	Edgar Link	completed
R19.htm	Edgar Link	completed
R2.htm	Edgar Link	completed
R20.htm	Edgar Link	completed
R21.htm	Edgar Link	completed
R22.htm	Edgar Link	completed
R23.htm	Edgar Link	completed
R24.htm	Edgar Link	completed
R25.htm	Edgar Link	completed
R26.htm	Edgar Link	completed
R27.htm	Edgar Link	completed
R28.htm	Edgar Link	completed
R29.htm	Edgar Link	completed
R3.htm	Edgar Link	completed
R30.htm	Edgar Link	completed
R31.htm	Edgar Link	completed
R32.htm	Edgar Link	completed
R33.htm	Edgar Link	completed
R34.htm	Edgar Link	completed
R35.htm	Edgar Link	completed
R36.htm	Edgar Link	completed
R37.htm	Edgar Link	completed
R38.htm	Edgar Link	completed
R39.htm	Edgar Link	completed
R4.htm	Edgar Link	completed
R40.htm	Edgar Link	completed
R41.htm	Edgar Link	completed
R42.htm	Edgar Link	completed
R43.htm	Edgar Link	completed
R44.htm	Edgar Link	completed
R45.htm	Edgar Link	completed
R46.htm	Edgar Link	completed
R47.htm	Edgar Link	completed
R48.htm	Edgar Link	completed
R49.htm	Edgar Link	completed
R5.htm	Edgar Link	completed
R50.htm	Edgar Link	completed
R51.htm	Edgar Link	completed
R52.htm	Edgar Link	completed
R53.htm	Edgar Link	completed
R54.htm	Edgar Link	completed
R55.htm	Edgar Link	completed
R56.htm	Edgar Link	completed
R57.htm	Edgar Link	completed
R58.htm	Edgar Link	completed
R59.htm	Edgar Link	completed
R6.htm	Edgar Link	completed
R60.htm	Edgar Link	completed
R61.htm	Edgar Link	completed
R62.htm	Edgar Link	completed
R63.htm	Edgar Link	completed
R64.htm	Edgar Link	completed
R65.htm	Edgar Link	completed
R66.htm	Edgar Link	completed
R67.htm	Edgar Link	completed
R68.htm	Edgar Link	completed
R69.htm	Edgar Link	completed
R7.htm	Edgar Link	completed
R70.htm	Edgar Link	completed
R71.htm	Edgar Link	completed
R72.htm	Edgar Link	completed
R73.htm	Edgar Link	completed
R74.htm	Edgar Link	completed
R75.htm	Edgar Link	completed
R76.htm	Edgar Link	completed
R77.htm	Edgar Link	completed
R78.htm	Edgar Link	completed
R79.htm	Edgar Link	completed
R8.htm	Edgar Link	completed
R80.htm	Edgar Link	completed
R81.htm	Edgar Link	completed
R82.htm	Edgar Link	completed
R83.htm	Edgar Link	completed
R84.htm	Edgar Link	completed
R9.htm	Edgar Link	completed
R9999.htm	Edgar Link	completed
report.css	Edgar Link	completed
Show.js	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMD
ADVANCED MICRO DEVICES INC Stock $amd

2020 Q4 Form 10-K Financial Statement

#000162828021001185 Filed on January 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMD ADVANCED MICRO DEVICES INC Stock $amd

2020 Q4 Form 10-K Financial Statement

#000162828021001185 Filed on January 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMD
ADVANCED MICRO DEVICES INC Stock $amd